The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Alfimova M.V.

Nauchnyĭ tsentr psikhicheskogo zdorov'ia RAMN

Abramova L.I.

Nauchnyĭ tsentr psikhicheskogo zdorov'ia RAMN, Moskva

Aksenova E.V.

Tsentr semeĭnoĭ meditsiny "Zdravitsa", Novosibirsk

Golubev S.A.

Frolova L.F.

Ganisheva T.K.

Shemiakina T.K.

Orlov V.A.

NII skoroĭ pomoshchi im. N.V. Sklifosovskogo;
kafedra klinicheskoĭ farmakologii i terapii RMAPO

Golimbet V.E.

Nauchnyĭ tsentr psikhicheskogo zdorov'ia RAMN, Moskva

The association between the NRG1 gene polymorphism and cognitive functions in patients with schizophrenia and healthy controls

Authors:

Alfimova M.V., Abramova L.I., Aksenova E.V., Golubev S.A., Frolova L.F., Ganisheva T.K., Shemiakina T.K., Orlov V.A., Golimbet V.E.

More about the authors

Read: 1226 times


To cite this article:

Alfimova MV, Abramova LI, Aksenova EV, et al. The association between the NRG1 gene polymorphism and cognitive functions in patients with schizophrenia and healthy controls. S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(6):53‑57. (In Russ.)

Recommended articles:
Modern concepts of sleep disturbances asso­ciated with mental diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):7-12
Factors supporting chro­nic inflammation in mental illness. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):7-15
Search for info­rmative predictors of the deve­lopment and progression of multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):124-130
Atte­ntion defi­cit hype­ractivity diso­rder: pharmacotherapy in special situations. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(10):59-65
Constitutional and morphological bases of suicidal beha­vior in patients with schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(11):52-56
Search for risk factors for slowed intra-atrial conduction in patients with schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(11):111-116
Obstructive sleep apnea as an aggravating factor of cognitive impairment in vascular cognitive diso­rder. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(11):151-156

References:

  1. Addington A.M., Gornick M.C., Shaw P. et al.Neuregulin 1 (8p12) and childhood-onset schizophrenia: susceptibility haplotypes for diagnosis and brain developmental trajectories. Mol Psychiatry 2007; 12: 195-205.
  2. Bakker S.C., Hoogendoorn M.L., Selten J.P. et al.Neuregulin 1: genetic support for schizophrenia subtypes. Mol Psychiatry 2004; 9: 12: 1061-1063.
  3. Bellon A.New genes associated with schizophrenia in neurite formation: a review of cell culture experiments. Mol Psychiatry 2007; 12: 620-629.
  4. Bramon E., Dempster E., Frangou S. et al.Neuregulin-1 and the P300 waveform - a preliminary association study using a psychosis endophenotype. Schizophr Res 2008; 103: 1-3: 178-185.
  5. Chaudhury A.R., Gerecke K.M., Wyss J.M. et al.Neuregulin-1 and erbB4 immunoreactivity is associated with neuritic plaques in Alzheimer disease brain and in a transgenic model of Alzheimer disease. J Neuropathol Exp Neurol 2003; 62: 42-54.
  6. Gardner M., Gonzalez-Neira A., Lao O. et al.Extreme population differences across Neuregulin 1 gene, with implications for association studies. Mol Psychiatry 2006; 11: 66-75.
  7. Georgieva L., Dimitrova A., Ivanov D. et al.Support for Neuregulin 1 as a susceptibility gene for bipolar disorder and schizophrenia. Biol Psychiatry 2008; 64: 419-427.
  8. Gong Y.G., Wue C.N., Xing Q.H. et al.A two-method meta-analysis of Neuregulin 1(NRG1) association and heterogeneity in schizophrenia. Schizophr Res 2009; 111: 109-114.
  9. Joo Y.H.Neurophyisological and neurocognitive endophenotypes for schizophrenia genetics research. Psychiatry Invest 2008; 5: 199-202.
  10. Kircher T., Krug A., Markov V. et al.Genetic variation in the schizophrenia-risk gene neuregulin 1 correlates with brain activation and impaired speech production in a verbal fluency task in healthy individuals. Hum Brain Mapp 2009; 30: 10: 3406-3416.
  11. Kircher T., Thienel R., Wagner M. et al.Neuregulin 1 ICE-single nucleotide polymorphism in first episode schizophrenia correlates with cerebral activation in fronto-temporal areas. Eur Arch Psychiatry Clin Neurosci 2009; 259: 2: 72-79.
  12. Krug A., Markov V., Eggermann T. et al.Genetic variation in the schizophrenia-risk gene neuregulin1 correlates with differences in frontal brain activation in a working memory task in healthy individuals. Neuroimage 2008; 42: 4: 1569-1576.
  13. Krug A., Markov V., Krach S. et al.The effect of Neuregulin 1 on neural correlates of episodic memory encoding and retrieval. Neuroimage 2010; 53: 3: 985-991.
  14. Law A.J., Weickert C.S., Hyde T.M. et al.Neuregulin-1 (NRG-1) mRNA and protein in the adult human brain. Neuroscience 2004; 127: 125-136.
  15. Mechelli A., Prata D.P., Fu C.H. et al.The effects of neuregulin1 on brain function in controls and patients with schizophrenia and bipolar disorder. Neuroimage 2008; 42: 2: 817-826.
  16. Mechelli A., Viding E., Pettersson-Yeo W. et al.Genetic variation in neuregulin1 is associated with differences in prefrontal engagement in children. Hum Brain Mapp 2009; 30: 12: 3934-3943.
  17. Panutsopulos D., Arvanitis D.L., Tsatsanis C. et al.Expression of heregulin in human coronary atheroscleroticlesions. J Vasc Res 2005; 42: 463-474.
  18. Schmitt A., Parlapani E., Gruber O. et al.Impact of neuregulin-1 on the pathophysiology of schizophrenia in human post-mortem studies. Eur Arch Psychiatry Clin Neurosci 2008; 258: Suppl 5: 35-39.
  19. Stefanis N.C., Trikalinos T.A., Avramopoulos D. et al.Impact of schizophrenia candidate genes on schizotypy and cognitive endophenotypes at the population level. Biol Psychiatry 2007; 62: 784-792.
  20. Stefansson H., Sigurdsson E., Steinthorsdottir V. et al.Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Gen 2002; 71: 877-892.
  21. Stefansson H., Sarginson J., Kong A. et al.Association of Neuregulin 1 with schizophrenia confirmed in a Scottish population. Am J Hum Genet 2003; 72: 83-87.
  22. Szoke A., Schurhoff F., Mathieu F. et al.Tests of executive functions in first-degree relatives of schizophrenic patients: a meta-analysis. Psychol Med 2005; 35: 6: 771-782.
  23. Tan W., Wang Y., Gold B. et al.Molecular cloning of a brain-specific, developmentally regulated neuregulin 1 (NRG1) isoform and identification of a functional promoter variant associated with schizophrenia. J Biol Chem 2007; 282: 33: 24343-24351.
  24. Tosato S., Dazzan P., Collier D.Association between the Neuregulin 1 gene and schizophrenia: a systematic review. Schizophr Bull 2005; 31: 613-617.
  25. Wang F., Jiang T., Sun Z. et al.Neuregulin 1 genetic variation and anterior cingulum integrity in patients with schizophrenia and healthy controls. J Psychiatry Neurosci 2009; 34: 3: 181-186.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.